Market Overview

Uroplasty Announces Issuance of New Apparatus Patent for the Urgent PC Neuromodulation System Stimulator

Uroplasty, Inc. (NASDAQ: UPI) today announced the issuance of United States Patent No. 8,046,082 covering the stimulator used in the Urgent® PC Neuromodulation System. The Urgent PC Neuromodulation System is an office-based, non-surgical system, used to treat overactive bladder syndrome and the associated symptoms of urinary urge incontinence, urinary urgency and urinary frequency.

The new patent covers the reusable Urgent® PC stimulator. When connected to a thin needle electrode near the ankle to access the tibial nerve, the stimulator delivers current to the sacral nerve plexus that controls bladder and pelvic floor function.

Posted-In: News

 

Related Articles (UPI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters